Balchem (NASDAQ:BCPC – Get Free Report) is projected to post its Q1 2025 quarterly earnings results before the market opens on Thursday, April 24th. Analysts expect the company to announce earnings of $1.12 per share and revenue of $245.70 million for the quarter.
Balchem (NASDAQ:BCPC – Get Free Report) last posted its earnings results on Friday, February 21st. The basic materials company reported $1.03 EPS for the quarter, missing analysts’ consensus estimates of $1.11 by ($0.08). Balchem had a net margin of 13.47% and a return on equity of 11.37%. The firm had revenue of $240.00 million for the quarter, compared to the consensus estimate of $239.96 million. On average, analysts expect Balchem to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.
Balchem Stock Performance
Balchem stock opened at $156.92 on Tuesday. The company’s 50-day moving average price is $164.79 and its 200-day moving average price is $167.54. Balchem has a twelve month low of $137.69 and a twelve month high of $186.03. The company has a market cap of $5.11 billion, a PE ratio of 39.93, a price-to-earnings-growth ratio of 4.41 and a beta of 0.75. The company has a quick ratio of 1.16, a current ratio of 1.99 and a debt-to-equity ratio of 0.19.
Analyst Upgrades and Downgrades
View Our Latest Stock Analysis on BCPC
Balchem Company Profile
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.
Further Reading
- Five stocks we like better than Balchem
- What is the S&P 500 and How It is Distinct from Other Indexes
- Occidental Petroleum: Unpacking Its Onshore Oil & Gas Strength
- Industrial Products Stocks Investing
- Snap-on: Buy This Must-Own Dividend Stock While It’s Down
- Growth Stocks: What They Are, What They Are Not
- AST SpaceMobile: 5 Reasons to Buy This Tiny Trailblazer Stock
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.